Participation in Procurement of Tissue, Serum, Plasma, Cell Bank, DNA and RNA Samples, and Urine for Biological Studies Related to Prostate Cancer and Prostate Cancer Treatment Follow Up

Inclusion Criteria:

Informed consent explained and signed prior to any study related procedures.
Age ≥18 years
Eastern Cooperative Oncology Group (ECOG) performance status of 2 or better, or Karnofsky performance of 60% or better.
Histologically confirmed adenocarcinoma of the prostate within 10 years of study entry.
Willingness to return to Mayo Clinic Rochester for follow-up or participate in mail-in PSA processing.
Must be disease-free from a previous diagnosis of cancer for a period of time = 5 years excluding cutaneous malignancies of squamous cell or basal cell carcinoma.

Exclusion Criteria:

Life expectancy < 5 years.
Inability to return to Mayo Rochester for follow-up appointments, sera, and urine collection per protocol.
Previous or a concurrent diagnosis of cancers other than basal cell or invasive squamous cell carcinoma of skin within the past 5 years.